Medication management Archive

Proton pump inhibitors can calm severe reflux and heal the esophagus, but long-term use raises questions about when and how to cut back safely.

In late 2025, the FDA approved a nasal spray to treat a sporadic, rapid heart rhythm called paroxysmal supraventricular tachycardia (PSVT). The self-administered spray, called etripamil (Cardamyst), may help people avoid emergency room treatment for PSVT.

Social media posts tend to exaggerate side effects (such as muscle aches and memory problems) associated with statins and may spread invalid information about these drugs. This misinformation is a major threat to public health, according to a 2025 article.

After an FDA panel was convened to review black box warnings on menopause hormone therapy, which includes both systemic and vaginal estrogen treatments, the FDA announced in November 2025 it would remove black box warnings from all hormone therapy products containing estrogen. Women considering hormone therapy should discuss their individual health risks with their doctor - such as a history of heart attack or stroke, a blood clot in the legs or lungs, hormone-sensitive cancer, active liver disease, and overall breast cancer and cardiovascular risks.